To drive collaboration to control cost, reduce waste and maximize effectiveness of specialty drugs, the National Alliance and its member coalitions have developed stakeholder guidelines and an engagement framework targeting critical issues and opportunities for specialty stakeholders including manufacturers, providers, health plans, and pharmacy benefit managers.